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Abstract
Shwachman–Diamond syndrome (SDS) is a rare autosomal recessive disorder characterized by exocrine pancreatic insufficiency, bone marrow
dysfunction, and skeletal abnormalities. The Shwachman–Bodian–Diamond syndrome (SBDS) gene was identified as a causative gene for SDS in
2003, and genetic analyses of SDS have been performed. Over the last 4 years, a number of different mutations affecting the SBDS gene have been
described. In this report, a summary of documented SDS associated mutations is provided.
© 2007 Elsevier Inc. All rights reserved.
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Shwachman–Diamond syndrome (SDS; MIM# 260400) is a
rare autosomal recessive disorder, described for the first time in
1964 [1], characterized by the association of exocrine pancreatic
and bone marrow dysfunctions. Other systemic findings (skeletal,
liver and psychomotor) and/or problems secondary to bone mar-
row dysfunction may also be detected [1–4]. Intermittent or per-
sistent neutropenia is the most common hematologic finding, but
anemia and thrombocytopenia can also been present in approx-
imately 40% of the patients [1–5].
In 2002, fine mapping identified the locus for SDS in band
7q11. More recently (2003), Boocock et al. [6] identified 18
positional candidate genes in this locus, and examined eight of
them for occurrence of SDS-associated changes. They found
alterations only in a previously uncharacterized gene. This gene,
designated SBDS (Shwachman–Bodian–Diamond syndrome),
is composed of five exons spanning 7.9 kb. The authors also
described a pseudogene (SBDSP; MIM# 607444), with 97%
homology to SBDS [5–7]. SBDS comprises five exons spanning
7.9 kb, with a 1.6 kb transcript that translates into a protein of
250 amino acids [6,7]. The SBDS protein is a member of a
highly conserved family with orthologs in several species.
Although its function remains to be elucidated, studies revealing
ubiquitous expression with accumulation in the nucleolus in a
cell-cycle-dependent manner, as well as structural and co-ex-
pression studies in the yeast orthologs, provide strong evidence
for its role in ribosome biogenesis [7,8].
In the molecular analysis of the SBDS gene, the presence of
a hotspot region in and around exon 2 has facilitated diag-
nosis, and direct sequencing of this region has enabled the
detection of at least one mutated allele in about 90% of SDS
patients [5].
Shwachman–Diamond syndrome genemutations are shown in
Table 1. The nucleotide numbers shown in this table are based
on the cDNA sequence of GenBank accession number
NM_016038.2. Mutation nomenclature was according to the
recommendations of theHumanGenomeVariationSociety (2005)
(http://www.hgvs.org/mutnomen), using the numbering conven-
tion which assigns “1” to the A of the initiator ATG codon.
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Table 1
SBDS gene mutations in Shwachman–Diamond syndrome
cDNA nucleotide substitution Amino acid substitution Mutation type Reference Comments
c.24CNA p.N8K Substitution [6]
c.95ANG p.Y32C Substitution [9]
c.96_97insA p.N34fsX15 Insertion; frameshift [6]
c.101ANT p.N34I Substitution [9]
c.119delG p.S41fsX17 Deletion; frameshift [6]
[c.129-443ANG; c.129-433GNA; c.141CNT;
c.183_184TANCT; c.201ANG; c.258+2TNC]
p.K62X Substitution; Stop mutation [9] a)
c.131ANG p.E44G Substitution [6]
[c.141CNT; c.183_184TANCT] p.K62X Substitution; Stop mutation [9] a)
[c.141CNT; c.183_184TANCT; c.201ANG] p.K62X Substitution; [10] a)
Stop mutation
[c.141CNT; c.183_184TANCT; c.201ANG;
c.258+2TNC]
p.K62X Substitution; stop mutation [9] a)
c.183_184TANCT p.K62X Substitution; stop mutation [6] a)
[c.183_184TANCT; c.201ANG] p.K62X Substitution; stop mutation [10] a)
c.199ANG p.K67E Substitution [6]
[c.201ANG; c.258+2TNC] p.C84fsX3 Substitution; frameshift [9] a)
c.258+2TNC p.C84fsX3 Substitution; frameshift [6] a)
c.258+1GNC p.C84fsX3 Substitution; frameshift [6]
c.258+374_459+250del p.I87_Q153del Gross deletion [11] b)
c.259-1GNA No cDNA studies performed Predicted splice mutation [12]
c.260TNG p.I87S Substitution [6]
c.291_293TAAdelinsAGTTCAAGTATC p.D97_K98delinsEVQVS Deletion; insertion [6]
c.292_295delAAAG p.E99fsX20 Deletion; frameshift [10] a)
c.307_308delCA p.Q103fsX8 Deletion frameshift [9]
c.362ANC p.N121T Substitution [13]
c.377GNC p.R126T Substitution [6]
c.428CNG p.S143W Substitution [12]
c.505CNT p.R169C Substitution [6]
c.523CNT p.R175W Substitution [13]
c.624+1GNC No cDNA studies performed Predicted splice mutation [9]
c.635TNC p.I212T Substitution [6]
c.652CNT p.R218X Substitution; stop mutation [9]
a) These mutations result from conversion events between SBDS and SBDSP genes. b) Alu-mediated homologous recombination is the mechanism proposed for this
mutation.
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